American International Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,709
| Closed | -$2.1M | – | 3085 |
|
|
2019
Q3 | $2.1M | Sell |
21,709
-150
| -0.7% | -$15K | 0.01% | 961 |
|
|
2019
Q2 | $2.24M | Buy |
21,859
+1,802
| +9% | +$194K | 0.01% | 958 |
|
|
2019
Q1 | $2.28M | Sell |
20,057
-649
| -3% | -$47.7K | 0.01% | 957 |
|
|
2018
Q4 | $810K | Sell |
20,706
-160
| -0.8% | -$6.94K | ﹤0.01% | 1389 |
|
|
2018
Q3 | $1.14M | Buy |
20,866
+375
| +2% | +$25.6K | ﹤0.01% | 1362 |
|
|
2018
Q2 | $1.7M | Buy |
20,491
+2,824
| +16% | +$218K | 0.01% | 1085 |
|
|
2018
Q1 | $1.18M | Sell |
17,667
-951
| -5% | -$54.9K | ﹤0.01% | 1183 |
|
|
2017
Q4 | $957K | Buy |
18,618
+756
| +4% | +$54.3K | ﹤0.01% | 1393 |
|
|
2017
Q3 | $1.59M | Buy |
17,862
+3,442
| +24% | +$261K | 0.01% | 1086 |
|
|
2017
Q2 | $861K | Buy |
14,420
+2,838
| +25% | +$159K | ﹤0.01% | 1373 |
|
|
2017
Q1 | $618K | Buy |
11,582
+1,714
| +17% | +$102K | ﹤0.01% | 1463 |
|
|
2016
Q4 | $492K | Sell |
9,868
-27
| -0.3% | -$1.45K | ﹤0.01% | 1643 |
|
|
2016
Q3 | $594K | Buy |
9,895
+15
| +0.2% | +$865 | ﹤0.01% | 1511 |
|
|
2016
Q2 | $505K | Buy |
9,880
+5,166
| +110% | +$221K | ﹤0.01% | 1579 |
|
|
2016
Q1 | $139K | Hold |
4,714
| – | – | ﹤0.01% | 3113 |
|
|
2015
Q4 | $214K | Sell |
4,714
-209
| -4% | -$11K | ﹤0.01% | 2770 |
|
|
2015
Q3 | $205K | Buy |
4,923
+105
| +2% | +$5.48K | ﹤0.01% | 2805 |
|
|
2015
Q2 | $290K | Buy |
+4,818
| New | +$319K | ﹤0.01% | 2680 |
|
American International Group's ONCE Position: Q4 2019 in Review
American International Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 21,709 shares — an estimated $2.1M sold.
American International Group first reported a position in ONCE in Q2 2015 and held it in 18 quarters. The position peaked at $2.28M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- American International Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- American International Group sold 21,709 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.1M.
- American International Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 18 quarters.
- American International Group's Spark Therapeutics, Inc. Common Stock position peaked at $2.28M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on American International Group's 13F filing for Q4 2019, filed 5 Feb 2020.